WO2016099056A3 - 복령피 추출물을 함유하는 퇴행성 신경질환의 예방, 개선 또는 치료용 조성물 - Google Patents

복령피 추출물을 함유하는 퇴행성 신경질환의 예방, 개선 또는 치료용 조성물 Download PDF

Info

Publication number
WO2016099056A3
WO2016099056A3 PCT/KR2015/013136 KR2015013136W WO2016099056A3 WO 2016099056 A3 WO2016099056 A3 WO 2016099056A3 KR 2015013136 W KR2015013136 W KR 2015013136W WO 2016099056 A3 WO2016099056 A3 WO 2016099056A3
Authority
WO
WIPO (PCT)
Prior art keywords
preventing
neurodegenerative disorders
poria cocos
improving
bark extract
Prior art date
Application number
PCT/KR2015/013136
Other languages
English (en)
French (fr)
Other versions
WO2016099056A8 (ko
WO2016099056A2 (ko
Inventor
최상진
손미원
고효상
유자영
정진석
최성현
김은진
조영웅
김소영
Original Assignee
동아에스티 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DK15870223.3T priority Critical patent/DK3235502T3/da
Priority to SI201531202T priority patent/SI3235502T1/sl
Priority to EP19210811.6A priority patent/EP3632454B1/en
Priority to EP15870223.3A priority patent/EP3235502B1/en
Application filed by 동아에스티 주식회사 filed Critical 동아에스티 주식회사
Priority to RU2017123243A priority patent/RU2678982C2/ru
Priority to US15/535,478 priority patent/US10864238B2/en
Priority to BR112017012909-4A priority patent/BR112017012909B1/pt
Priority to JP2017532138A priority patent/JP6533294B2/ja
Priority to CN201580069243.3A priority patent/CN107106620A/zh
Publication of WO2016099056A2 publication Critical patent/WO2016099056A2/ko
Publication of WO2016099056A3 publication Critical patent/WO2016099056A3/ko
Publication of WO2016099056A8 publication Critical patent/WO2016099056A8/ko
Priority to CY20201100474T priority patent/CY1123293T1/el
Priority to US17/097,592 priority patent/US20210128656A1/en
Priority to CY20211100941T priority patent/CY1124945T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

본 발명의 복령피 (학명: Poria cocos) 추출물을 유효성분으로 함유하는 퇴행성 신경질환 예방 또는 치료용 약학적 조성물 및 퇴행성 신경질환 예방 또는 개선용 식품 조성물에 관한 것으로, 본 발명의 조성물에 포함되는 유효성분인 복령피 추출물은 베타아밀로이드 생성 및 타우 인산화 억제, NGF 생성 촉진작용을 통한 신경세포 보호작용, 신경세포 보호 및 아세틸콜린에스터라제 억제를 통한 기억력 개선작용을 가짐으로써, 퇴행성 신경질환 예방 또는 치료용 약학적 조성물, 또는 상기 목적의 건강식품으로 유용하게 사용될 수 있다.
PCT/KR2015/013136 2014-12-19 2015-12-03 복령피 추출물을 함유하는 퇴행성 신경질환의 예방, 개선 또는 치료용 조성물 WO2016099056A2 (ko)

Priority Applications (12)

Application Number Priority Date Filing Date Title
US15/535,478 US10864238B2 (en) 2014-12-19 2015-12-03 Composition containing Poria cocos peel extract for treating neurodegenerative disorders
EP19210811.6A EP3632454B1 (en) 2014-12-19 2015-12-03 Composition containing poria cocos bark extract for preventing, improving or treating neurodegenerative disorders
EP15870223.3A EP3235502B1 (en) 2014-12-19 2015-12-03 Composition containing poria cocos bark extract for preventing, improving or treating neurodegenerative disorders
JP2017532138A JP6533294B2 (ja) 2014-12-19 2015-12-03 茯苓皮抽出物を含有する退行性神経疾患の予防、改善または治療用組成物
RU2017123243A RU2678982C2 (ru) 2014-12-19 2015-12-03 Состав, содержащий экстракт кожицы poria cocos, предназначенный для профилактики, облегчения состояния и лечения нейродегенеративных расстройств
SI201531202T SI3235502T1 (sl) 2014-12-19 2015-12-03 Sestavek, ki vsebuje ekstrakt skorje poria cocos za preprečevanje, izboljšanje ali zdravljenje nevrodegenerativnih motenj
BR112017012909-4A BR112017012909B1 (pt) 2014-12-19 2015-12-03 Composição contendo extrato de casca de poria cocos para a prevenção, melhora ou tratamento de distúrbios neurodegenerativos
DK15870223.3T DK3235502T3 (da) 2014-12-19 2015-12-03 Sammensætning indeholdende poria cocos-barkekstrakt til forebyggelse, forbedring eller behandling af neurodegenerative lidelser
CN201580069243.3A CN107106620A (zh) 2014-12-19 2015-12-03 预防、改善或治疗退行性神经系统疾病的含茯苓皮提取物的组合物
CY20201100474T CY1123293T1 (el) 2014-12-19 2020-05-25 Συνθεση που περιεχει εκχυλισμα του φλοιου poria cocos για την προληψη, τη βελτιωση ή τη θεραπευτικη αντιμετωπιση των νευροεκφυλιστικων διαταραχων
US17/097,592 US20210128656A1 (en) 2014-12-19 2020-11-13 Composition containing poria cocos peel extract for treating neurodegenerative disorders
CY20211100941T CY1124945T1 (el) 2014-12-19 2021-11-02 Συνθεση περιεχουσα εκχυλισμα του φλοιου του poria cocos για προληψη, βελτιωση ή αγωγη νευροεκφυλιστικων διαταραχων

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2014-0184853 2014-12-19
KR1020140184853A KR101698163B1 (ko) 2014-12-19 2014-12-19 복령피 추출물을 함유하는 퇴행성 신경질환의 예방, 개선 또는 치료용 조성물

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US15/535,478 A-371-Of-International US10864238B2 (en) 2014-12-19 2015-12-03 Composition containing Poria cocos peel extract for treating neurodegenerative disorders
US17/097,592 Continuation US20210128656A1 (en) 2014-12-19 2020-11-13 Composition containing poria cocos peel extract for treating neurodegenerative disorders

Publications (3)

Publication Number Publication Date
WO2016099056A2 WO2016099056A2 (ko) 2016-06-23
WO2016099056A3 true WO2016099056A3 (ko) 2016-08-11
WO2016099056A8 WO2016099056A8 (ko) 2017-06-29

Family

ID=56127796

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2015/013136 WO2016099056A2 (ko) 2014-12-19 2015-12-03 복령피 추출물을 함유하는 퇴행성 신경질환의 예방, 개선 또는 치료용 조성물

Country Status (12)

Country Link
US (2) US10864238B2 (ko)
EP (2) EP3235502B1 (ko)
JP (1) JP6533294B2 (ko)
KR (1) KR101698163B1 (ko)
CN (2) CN113712998A (ko)
BR (1) BR112017012909B1 (ko)
CY (2) CY1123293T1 (ko)
DK (2) DK3632454T3 (ko)
HU (2) HUE049254T2 (ko)
RU (1) RU2678982C2 (ko)
SI (2) SI3632454T1 (ko)
WO (1) WO2016099056A2 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6844829B2 (ja) * 2016-07-21 2021-03-17 日本メナード化粧品株式会社 幹細胞の未分化状態維持剤及び増殖促進剤
MY195806A (en) * 2016-09-06 2023-02-22 Sinphar Tian Li Pharmaceutical Co Ltd Hangzhou Use of Poria Extract and Active Ingredient Thereof in Skin Care and/or Promoting Wound Healing
CN111759915A (zh) * 2020-07-20 2020-10-13 南通大学 一种神经再生复方制剂及其制备方法和用途

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029764A1 (fr) * 1996-02-15 1997-08-21 Daiichi Pharmaceutical Co., Ltd. Activateurs cerebraux
KR20050092292A (ko) * 2004-03-15 2005-09-21 주식회사 크라우젠 기억력 증강 효과가 있는 생약재 조성물
KR20100070514A (ko) * 2008-12-18 2010-06-28 대구한의대학교산학협력단 복신 건조분말 또는 그 추출물을 유효성분으로 함유하는건망증 및 기억력 장애 관련 질환의 예방 및 치료용 조성물
CN103393809A (zh) * 2013-07-24 2013-11-20 张立东 治疗帕金森的药物
KR20140074146A (ko) * 2012-12-06 2014-06-17 한국식품연구원 복령피 추출물을 유효성분으로 포함하는 Th1-매개 면역 질환 또는 Th2-매개 면역 질환의 예방, 개선 또는 치료용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192673A (en) * 1979-02-02 1984-07-06 Merck & Co Inc Ophthalmic compositions for lowering intraocular pressure
KR100615389B1 (ko) * 2002-08-23 2006-08-25 (주)헬릭서 다래 추출물을 함유하는 알러지성 질환 및 비알러지성염증 질환의 예방 및 개선용 건강 기능 식품
KR100526628B1 (ko) 2003-03-21 2005-11-08 주식회사 에스티씨나라 모노아민산화효소 저해활성을 갖는 상심자 추출물을함유한 조성물
KR100779179B1 (ko) * 2006-05-19 2007-11-28 충북대학교 산학협력단 토복령의 메탄올 추출물을 함유하는 뇌신경 보호 또는퇴행성뇌질환 예방 또는 치료제
KR100847343B1 (ko) * 2006-12-08 2008-07-21 경희대학교 산학협력단 생약복합재 추출물을 함유하는 골길이 성장 촉진용 조성물
CN101152554A (zh) 2007-09-24 2008-04-02 徐大洋 治疗荨麻疹既泄热消疹的中药
KR20090071704A (ko) * 2007-12-28 2009-07-02 퓨리메드 주식회사 치매 예방 및 치료용 조성물
KR101064258B1 (ko) 2008-12-29 2011-09-14 한국과학기술연구원 벤조아릴우레이도 화합물, 및 이를 함유하는 퇴행성 뇌질환예방 또는 치료용 조성물
KR20100083632A (ko) * 2009-01-14 2010-07-22 울산대학교 산학협력단 표적 단백질 분해효소 감응형 항암제 전구체
KR20110119983A (ko) 2010-04-28 2011-11-03 순천대학교 산학협력단 뽕나무 열매 추출물을 함유하는 아세틸콜린에스테라제 억제용 조성물
CN102133351B (zh) 2011-03-04 2012-05-09 费萍 一种治疗阿尔茨海默病的药物组合物及其制备方法
CN102133242B (zh) * 2011-03-07 2013-12-11 北京中医药大学 一种茯苓提取物及其制备方法
JP2013234178A (ja) 2012-04-12 2013-11-21 Kracie Seiyaku Kk 細胞死抑制組成物
KR101251866B1 (ko) 2012-07-12 2013-04-10 순천대학교 산학협력단 뽕나무 열매 추출물을 함유하는 아세틸콜린에스테라제 억제용 조성물
WO2014088200A1 (ko) * 2012-12-06 2014-06-12 한국식품연구원 복령피 추출물, 백미 추출물 또는 남성 추출물을 유효성분으로 포함하는 면역 질환의 예방, 개선 또는 치료용 조성물
CN104013891A (zh) * 2014-05-28 2014-09-03 高益槐 一种益智健脑的复方制剂及其制备方法
KR101671437B1 (ko) 2014-12-19 2016-11-01 동아에스티 주식회사 상심자 및 복령피 혼합 추출물을 함유하는 퇴행성 신경질환의 예방, 개선 또는 치료용 조성물

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029764A1 (fr) * 1996-02-15 1997-08-21 Daiichi Pharmaceutical Co., Ltd. Activateurs cerebraux
KR20050092292A (ko) * 2004-03-15 2005-09-21 주식회사 크라우젠 기억력 증강 효과가 있는 생약재 조성물
KR20100070514A (ko) * 2008-12-18 2010-06-28 대구한의대학교산학협력단 복신 건조분말 또는 그 추출물을 유효성분으로 함유하는건망증 및 기억력 장애 관련 질환의 예방 및 치료용 조성물
KR20140074146A (ko) * 2012-12-06 2014-06-17 한국식품연구원 복령피 추출물을 유효성분으로 포함하는 Th1-매개 면역 질환 또는 Th2-매개 면역 질환의 예방, 개선 또는 치료용 조성물
CN103393809A (zh) * 2013-07-24 2013-11-20 张立东 治疗帕金森的药物

Also Published As

Publication number Publication date
EP3632454A1 (en) 2020-04-08
CN113712998A (zh) 2021-11-30
EP3235502A2 (en) 2017-10-25
DK3235502T3 (da) 2020-06-02
EP3235502B1 (en) 2020-02-26
EP3632454B1 (en) 2021-08-11
KR101698163B1 (ko) 2017-01-19
BR112017012909A2 (pt) 2018-01-09
JP6533294B2 (ja) 2019-06-19
HUE056404T2 (hu) 2022-02-28
US20170368122A1 (en) 2017-12-28
CY1124945T1 (el) 2023-01-05
RU2017123243A3 (ko) 2019-01-21
RU2017123243A (ru) 2019-01-21
RU2678982C2 (ru) 2019-02-05
HUE049254T2 (hu) 2020-09-28
SI3632454T1 (sl) 2021-11-30
JP2018500331A (ja) 2018-01-11
DK3632454T3 (da) 2021-11-08
US20210128656A1 (en) 2021-05-06
BR112017012909B1 (pt) 2021-06-15
CN107106620A (zh) 2017-08-29
CY1123293T1 (el) 2021-12-31
KR20160075183A (ko) 2016-06-29
WO2016099056A8 (ko) 2017-06-29
EP3235502A4 (en) 2018-07-18
SI3235502T1 (sl) 2020-07-31
US10864238B2 (en) 2020-12-15
WO2016099056A2 (ko) 2016-06-23

Similar Documents

Publication Publication Date Title
WO2016004068A8 (en) Hydrogel compositions comprising encapsulated cells and methods of use thereof
WO2018019823A8 (en) Administration and dosage of diaminophenothiazines
WO2014159628A3 (en) Preventing or delaying chill injury response in plants
CY1124857T1 (el) Συνθεση που περιεχει μεικτο εκχυλισμα μουρων και φλοιου poria cocos για προληψη, βελτιωση ή θεραπεια νευροεκφυλιστικων διαταραχων
PH12017500706A1 (en) Composition containing extract or fraction of genus justicia plant
PH12017500615A1 (en) Ophthalmic composition comprising cyclosporine and trehalose
TN2019000032A1 (en) Pharmaceutical compositions and uses directed to lysosomal storage disorders
UY36432A (es) Combinaciones de compuestos activos que comprenden un derivado de (tio) carboxamida y compuesto(s) fungicida(s)
WO2016099056A3 (ko) 복령피 추출물을 함유하는 퇴행성 신경질환의 예방, 개선 또는 치료용 조성물
EP3413904A4 (en) PLANT-BASED COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF PLANT INFECTIONS OR UNGALEAL INFECTIONS
EP3295946A4 (en) Composition, containing lithospermi radix extract as active ingredient, for preventing, alleviating, or treating peripheral neuropathy
WO2018088813A3 (ko) Nkx3.2 단편 및 이를 유효성분으로 포함하는 약학 조성물
MX2019001634A (es) Compuestos amidas, composiciones farmacéuticas de estos y métodos para utilizarlos.
WO2016178510A3 (ko) 진세노사이드 F1 또는 Rg3를 유효성분으로 포함하는 글리벡 내성 백혈병 예방 또는 치료용 약학 조성물
WO2016186349A3 (ko) 사군자 추출물을 함유하는 전립선 비대증 예방 또는 치료용 조성물
MX2017003360A (es) Composicion para la prevencion y/o tratamiento de sintomas de alergia.
EP3144005A4 (en) Composition for preventing and treating male infertility, containing mixed herbal extract as active ingredient and use thereof
WO2016072692A3 (ko) 네크록스를 유효성분으로 함유하는 점막염 예방 또는 치료용 조성물
EP3533450A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ISCHEMIA-REPERFUSION DAMAGE, CONTAINING BILIARY ACID
WO2016178490A3 (ko) 곰보배추 추출물 또는 이의 분획물을 포함하는 통풍 예방 또는 치료용 약학적 조성물 및 고요산혈증 개선용 식품 조성물
EA201791483A1 (ru) Фармацевтическая композиция для лечения микоза
WO2016144704A3 (en) Heterocyclic autotaxin inhibitor compounds
EP3417867A4 (en) COMPOSITION WITH MEDICINAL EXTRACT AS ACTIVE AGENT FOR PREVENTING, DISABLING, OR TREATING STRESS OR DEPRESSIONS
TR201906539T4 (tr) Mentol, Linalool ve/veya Icilin Kullanarak Beyin Travması ve İnmelerden Kaynaklanan Non-İnflamatuar Nöron Hasarının Tedavisi veya Önlenmesi.
WO2016164719A3 (en) Methods used to treat cancer

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15870223

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 15535478

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2017532138

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2015870223

Country of ref document: EP

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112017012909

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 2017123243

Country of ref document: RU

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 112017012909

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20170615